Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 3034

1.

Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.

Sandesara PB, Hammadah M, Samman-Tahhan A, Kelli HM, O'Neal WT.

Clin Cardiol. 2017 Apr 26. doi: 10.1002/clc.22716. [Epub ahead of print]

PMID:
28444995
2.

The Association between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease.

Andrijevic L, Milutinov S, Andrijevic I, Jokic D, Vukoja M.

Balkan Med J. 2017 Apr 6. doi: 10.4274/balkanmedj.2016.1114. [Epub ahead of print]

PMID:
28443567
3.

CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction.

de Denus S, Rouleau JL, Mann DL, Huggins GS, Pereira NL, Shah SH, Cappola TP, Fouodjio R, Mongrain I, Dubé MP.

Pharmacogenomics J. 2017 Apr 25. doi: 10.1038/tpj.2017.8. [Epub ahead of print]

PMID:
28440343
4.

Cardiomyocyte Ca<sup>2+</sup> homeostasis as a therapeutic target in heart failure with reduced and preserved ejection fraction.

Peana D, Domeier TL.

Curr Opin Pharmacol. 2017 Apr 21;33:17-26. doi: 10.1016/j.coph.2017.03.005. [Epub ahead of print] Review.

PMID:
28437711
5.

Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure with Preserved Ejection Fraction: the Critical Play Off between a 'Pure' Patient Phenotype and the Generalizability of Trial Findings.

Patel HC, Hayward C, Dungu J, Papadopoulou S, Saidmeerasah A, Di Mario C, Shanmugam N, Cowie MR, Anderson LJ.

J Card Fail. 2017 Apr 18. pii: S1071-9164(17)30099-4. doi: 10.1016/j.cardfail.2017.04.006. [Epub ahead of print]

PMID:
28434933
6.

A humanized HLA-DR4 mouse model for autoimmune myocarditis.

Şelli ME, Thomas AC, Wraith DC, Newby AC.

J Mol Cell Cardiol. 2017 Apr 18;107:22-26. doi: 10.1016/j.yjmcc.2017.04.003. [Epub ahead of print]

PMID:
28431892
7.

Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease.

Borlaug BA, Obokata M.

Eur Heart J. 2017 Apr 17. doi: 10.1093/eurheartj/ehx184. [Epub ahead of print] No abstract available.

PMID:
28431020
8.

Reduced arteriovenous oxygen difference in heart failure with preserved ejection fraction patients: Is the muscle oxidative phenotype certainly involved?

Montero D, Lundby C.

Eur J Prev Cardiol. 2017 Jan 1:2047487317706587. doi: 10.1177/2047487317706587. [Epub ahead of print] No abstract available.

PMID:
28429959
9.

Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population.

Davis JM 3rd, Lin G, Oh JK, Crowson CS, Achenbach SJ, Therneau TM, Matteson EL, Rodeheffer RJ, Gabriel SE.

Int J Cardiol. 2017 Mar 31. pii: S0167-5273(16)34189-4. doi: 10.1016/j.ijcard.2017.03.108. [Epub ahead of print]

PMID:
28427850
10.

Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.

Abdul-Rahim AH, Perez AC, MacIsaac RL, Jhund PS, Claggett BL, Carson PE, Komajda M, McKelvie RS, Zile MR, Swedberg K, Yusuf S, Pfeffer MA, Solomon SD, Lip GYH, Lees KR, McMurray JJV; Candesartan in Heart failure Assessment of Reduction in Mortality and Morbidity-Preserved (CHARM-Preserved) and the Irbesartan in Heart Failure with Preserved Systolic Function (I-Preserve) Steering Committees..

Eur Heart J. 2017 Mar 7;38(10):742-750. doi: 10.1093/eurheartj/ehw509.

PMID:
28426886
11.

The fallacy of resting echocardiographic parameters of cardiac function in heart failure with preserved ejection fraction: add global longitudinal strain to the list.

Vinereanu D, Mǎrgulescu AD.

Eur J Heart Fail. 2017 Apr 19. doi: 10.1002/ejhf.828. [Epub ahead of print] No abstract available.

PMID:
28425164
12.

Contribution of Autonomic Reflexes to the Hyperadrenergic State in Heart Failure.

Toschi-Dias E, Rondon MUPB, Cogliati C, Paolocci N, Tobaldini E, Montano N.

Front Neurosci. 2017 Mar 30;11:162. doi: 10.3389/fnins.2017.00162. eCollection 2017. Review.

13.

Importance of SERCA2a on early isolated diastolic dysfunction induced by supravalvular aortic stenosis in rats.

Silveira CFSMP, Campos DHS, Freire PP, Deus AF, Okoshi K, Padovani CR, Cicogna AC.

Braz J Med Biol Res. 2017 Apr 13;50(5):e5742. doi: 10.1590/1414-431X20175742.

14.

Utility of Cardiovascular Magnetic Resonance-Derived Wave Intensity Analysis As a Marker of Ventricular Function in Children with Heart Failure and Normal Ejection Fraction.

Ntsinjana HN, Chung R, Ciliberti P, Muthurangu V, Schievano S, Marek J, Parker KH, Taylor AM, Biglino G.

Front Pediatr. 2017 Apr 3;5:65. doi: 10.3389/fped.2017.00065. eCollection 2017.

15.

New Classification for Heart Failure with Mildly Reduced Ejection Fraction: Greater clarity or more confusion?

Nadar S.

Sultan Qaboos Univ Med J. 2017 Feb;17(1):e23-e26. doi: 10.18295/squmj.2016.17.01.005. Epub 2017 Mar 30.

16.

Hypertension and heart failure with preserved ejection fraction: connecting the dots.

Tsioufis C, Georgiopoulos G, Oikonomou D, Thomopoulos C, Katsiki N, Kasiakogias A, Chrysochoou C, Konstantinidis D, Kalos T, Tousoulis D.

Curr Vasc Pharmacol. 2017 Apr 14. doi: 10.2174/1570161115666170414120532. [Epub ahead of print]

PMID:
28413968
17.

The Role of Estrogen in Cardiac Metabolism and Diastolic Function.

Li S, Gupte AA.

Methodist Debakey Cardiovasc J. 2017 Jan-Mar;13(1):4-8. doi: 10.14797/mdcj-13-1-4.

18.

RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: Stratification of Clinical Phenotypes and Outcomes.

Guazzi M, Dixon D, Labate V, Beussink-Nelson L, Bandera F, Cuttica MJ, Shah SJ.

JACC Cardiovasc Imaging. 2017 Apr 7. pii: S1936-878X(17)30251-6. doi: 10.1016/j.jcmg.2016.12.024. [Epub ahead of print]

PMID:
28412423
19.

Impaired Right Heart and Pulmonary Vascular Function in HFpEF: Time for More Risk Markers?

Kaye DM, Marwick TH.

JACC Cardiovasc Imaging. 2017 Apr 7. pii: S1936-878X(17)30248-6. doi: 10.1016/j.jcmg.2016.12.023. [Epub ahead of print] No abstract available.

PMID:
28412416
20.

Contemporary Approaches to Patients with Heart Failure.

Mitter SS, Yancy CW.

Cardiol Clin. 2017 May;35(2):261-271. doi: 10.1016/j.ccl.2016.12.008. Review.

PMID:
28411900

Supplemental Content

Loading ...
Support Center